CDXS logo

Codexis, Inc. (CDXS)

Profile

Full Name

Codexis, Inc.

Ticker

NASDAQ: CDXS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 22, 2010

Indexes

Not included

Website

https://www.codexis.com

Employees

188

Key Details

Price

$2.43(-0.41%)

Market cap

$219.35M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$59.34M(-15.39% YoY)

Annual EPS

-$0.89(+20.54% YoY)

PE ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.43
    CDXS price is $2.43

    30-Day Relative Volume

    0.44
    CDXS 30-day relative volume is 0.44

    Price Performance

    Price Most recent change

    -0.41%
    CDXS price was down -0.41% on Sep 12, 2025

    Price YTD change

    -49.06%
    CDXS price is down -49.06% since January 1st

    Price 1-year change

    -12.59%
    CDXS price is down -12.59% year-on-year

    Price 3-year change

    -66.44%
    CDXS price is down -66.44% over the past 3 years

    Price Range

    Price All-time high

    $42.01
    CDXS price is currently -94.22% below its historical high of $42.01

    Price 3-year low

    $1.45
    CDXS price is currently +67.59% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $219.35M
    CDXS market capitalization is $219.35 million

    Market cap 3-year change

    -53.74%
    CDXS market capitalization is down -53.74% over the past 3 years

    Market cap All-time high

    $2.71B
    CDXS market capitalization is currently -91.91% below its historical high of $2.71 billion

    Market cap sector rank

    51.68%
    CDXS market capitalization is higher than 51.68% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +27.27%
    CDXS shares outstanding is up +27.27% year-on-year

    Shares Outstanding 3-Year Change

    +37.83%
    CDXS shares outstanding is up +37.83% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.87
    CDXS beta is 1.87

    200-day SMA

    $3.27
    CDXS price is currently -25.68% below its 200-day simple moving average

    50-day SMA

    $2.80
    CDXS price is currently -13.12% below its 50-day simple moving average

    RSI

    36.43
    CDXS 14-day relative strength index is 36.43

    Volume

    0.44
    CDXS 30-day relative volume is 0.44

    ATR

    $0.15
    CDXS average true range is $0.15

    10-day Historical Volatility

    44.87%
    CDXS 10-day historical volatility is 44.87%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $59.34M
    CDXS annual revenue is $59.34 million

    Revenue Analysts estimate

    $65.66M
    CDXS annual revenue is currently -9.61% lower than the consensus analysts' forecast

    Revenue 1-year change

    -15.39%
    CDXS annual revenue is down -15.39% year-on-year

    Revenue Sector rank

    63.31%
    CDXS annual revenue is higher than 63.31% of companies in Healthcare sector

    EPS

    EPS

    -$0.89
    CDXS annual earnings per share is -$0.89

    EPS Analysts estimate

    -$0.60
    CDXS annual earnings per share is currently +48.33% higher than the consensus analysts' forecast

    EPS 1-year change

    +20.54%
    CDXS annual earnings per share is up +20.54% year-on-year

    EPS Sector rank

    54.37%
    CDXS annual earnings per share is higher than 54.37% of companies in Healthcare sector

    Profit

    Gross profit

    $43.06M
    CDXS annual gross profit is $43.06 million

    Gross margin

    72.55%
    CDXS annual gross profit margin is 72.55%

    Operating profit

    -$58.35M
    CDXS annual operating income is -$58.35 million

    Operating margin

    -98.33%
    CDXS annual operating profit margin is -98.33%

    Net income

    -$65.28M
    CDXS annual net profit is -$65.28 million

    Net margin

    -109.99%
    CDXS annual net profit margin is -109.99%

    Expenses

    Total expenses

    $117.70M
    CDXS annual total expenses is $117.70 million

    Operating expenses

    $101.41M
    CDXS annual total operating expenses is $101.41 million

    Cost of goods sold

    $16.29M
    CDXS annual cost of goods sold is $16.29 million

    Selling, general & administrative expenses

    $55.15M
    CDXS annual SGA is $55.15 million

    Depreciation and amortization

    $4.95M
    CDXS annual depreciation & amortization is $4.95 million

    Interest expense

    $0.00
    CDXS annual interest expense is $0.00

    Income tax

    $34.00K
    CDXS annual income tax is $34.00 thousand

    EBIT & EBITDA

    EBIT

    -$58.35M
    CDXS annual earnings before interest & taxes is -$58.35 million

    EBITDA

    -$53.41M
    CDXS annual EBITDA is -$53.41 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $149.01M
    CDXS annual total assets is $149.01 million

    Non current assets

    $50.24M
    CDXS annual long term assets is $50.24 million

    Current assets

    $98.77M
    CDXS annual total current assets is $98.77 million

    Cash and cash equivalents

    $19.26M
    CDXS annual cash & cash equivalents is $19.26 million

    Accounts receivable

    $11.92M
    CDXS annual accounts receivable is $11.92 million

    Inventory

    $1.80M
    CDXS annual inventory is $1.80 million

    Liabilities

    Total liabilities

    $82.08M
    CDXS annual total liabilities is $82.08 million

    Long term liabilities

    $58.44M
    CDXS annual total long term liabilities is $58.44 million

    Current liabilities

    $23.65M
    CDXS annual total current liabilities is $23.65 million

    Accounts payable

    $2.84M
    CDXS annual accounts payable is $2.84 million

    Debt

    Total debt

    $59.90M
    CDXS annual total debt is $59.90 million

    Total debt 1-year change

    +167.82%
    CDXS annual total debt is up +167.82% year-on-year

    Long term debt

    $57.07M
    CDXS annual long term debt is $57.07 million

    Short term debt

    $2.83M
    CDXS annual short term debt is $2.83 million

    Equity & Capital

    Shareholders equity

    $66.93M
    CDXS annual stockholders equity is $66.93 million

    Book value

    $66.93M
    CDXS annual book value is $66.93 million

    Retained earnings

    -$562.81M
    CDXS annual retained earnings is -$562.81 million

    Working capital

    $75.12M
    CDXS annual working capital is $75.12 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$49.41M
    CDXS annual cash flow from operations is -$49.41 million

    Cash from operations 1-year change

    +6.13%
    CDXS annual cash flow from operations is up +6.13% year-on-year

    Cash from investing

    -$56.98M
    CDXS annual cash flow from investing activities is -$56.98 million

    Cash from investing 1-year change

    -1072.91%
    CDXS annual cash flow from investing activities is down -1072.91% year-on-year

    Cash from financing

    $60.52M
    CDXS annual cash flow from financing activities is $60.52 million

    Cash from financing 1-year change

    +641.06%
    CDXS annual cash flow from financing activities is up +641.06% year-on-year

    CAPEX

    CAPEX

    $4.30M
    CDXS annual capital expenditures is $4.30 million

    CAPEX 1-year change

    -2.56%
    CDXS annual capital expenditures is down -2.56% year-on-year

    Free Cash Flow

    Free cash flow

    -$53.72M
    CDXS annual free cash flow is -$53.72 million

    Free cash flow 1-year change

    +5.86%
    CDXS annual free cash flow is up +5.86% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    72.55%
    CDXS annual gross profit margin is 72.55%

    Operating margin

    -98.33%
    CDXS annual operating profit margin is -98.33%

    Net margin

    -109.99%
    CDXS annual net profit margin is -109.99%

    ROA & ROE

    ROA

    -45.72%
    CDXS annual return on assets is -45.72%

    ROE

    -85.03%
    CDXS annual return on equity is -85.03%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CDXS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CDXS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    3.94
    CDXS price to book ratio is 3.94

    PB ratio Sector rank

    72.39%
    CDXS price to book ratio is higher than 72.39% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.84
    CDXS price to sales ratio is 3.84

    PS ratio Sector rank

    51.61%
    CDXS price to sales ratio is higher than 51.61% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $221.50M
    CDXS enterprise value is $221.50 million

    Enterprise value Sector rank

    56.55%
    CDXS enterprise value is higher than 56.55% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.43
    CDXS EV/EBITDA is -4.43

    EV/EBITDA Sector rank

    24.82%
    CDXS EV/EBITDA is higher than 24.82% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.18
    CDXS annual current ratio is 4.18

    Quick ratio

    4.10
    CDXS annual quick ratio is 4.10

    Leverage

    Debt to equity

    0.43
    CDXS annual debt to equity ratio is 0.43

    Interest coverage ratio

    -
    CDXS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    CDXS piotroski f-score is 3

    Altman Z-Score

    -3.97
    CDXS altman z-score is -3.97

    Analyst ratings

    Recent major analysts updates

    Nov 22, 24 Cantor Fitzgerald
    Overweight
    Nov 15, 24 Cantor Fitzgerald
    Overweight
    Nov 4, 24 Benchmark
    Hold
    Sep 20, 24 Cantor Fitzgerald
    Overweight
    Aug 29, 24 Cantor Fitzgerald
    Overweight
    Aug 19, 24 Benchmark
    Hold
    Aug 9, 24 Cantor Fitzgerald
    Overweight
    May 30, 24 Cantor Fitzgerald
    Overweight
    May 3, 24 Benchmark
    Buy
    Feb 29, 24 Benchmark
    Buy

    Institutional Ownership

    Screeners with CDXS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Codexis, Inc.?
    • Does Codexis, Inc. pay dividends?
    • What sector is Codexis, Inc. in?
    • What industry is Codexis, Inc. in?
    • What country is Codexis, Inc. based in?
    • When did Codexis, Inc. go public?
    • Is Codexis, Inc. in the S&P 500?
    • Is Codexis, Inc. in the NASDAQ 100?
    • Is Codexis, Inc. in the Dow Jones?
    • When was Codexis, Inc.'s last earnings report?
    • When does Codexis, Inc. report earnings?

    What is the ticker symbol for Codexis, Inc.?

    The ticker symbol for Codexis, Inc. is NASDAQ:CDXS

    Does Codexis, Inc. pay dividends?

    No, Codexis, Inc. does not pay dividends

    What sector is Codexis, Inc. in?

    Codexis, Inc. is in the Healthcare sector

    What industry is Codexis, Inc. in?

    Codexis, Inc. is in the Biotechnology industry

    What country is Codexis, Inc. based in?

    Codexis, Inc. is headquartered in United States

    When did Codexis, Inc. go public?

    Codexis, Inc.'s initial public offering (IPO) was on April 22, 2010

    Is Codexis, Inc. in the S&P 500?

    No, Codexis, Inc. is not included in the S&P 500 index

    Is Codexis, Inc. in the NASDAQ 100?

    No, Codexis, Inc. is not included in the NASDAQ 100 index

    Is Codexis, Inc. in the Dow Jones?

    No, Codexis, Inc. is not included in the Dow Jones index

    When was Codexis, Inc.'s last earnings report?

    Codexis, Inc.'s most recent earnings report was on August 13, 2025

    When does Codexis, Inc. report earnings?

    The next expected earnings date for Codexis, Inc. is October 30, 2025
    On this page